Klas Bratteby

Publications
Public outreach and news

Articles

Article: EJNMMI RADIOPHARMACY AND CHEMISTRY. 2024;9(1):35
GMP production of [18F]FE-PE2I on a TRACERLab FX2 N synthesis module, a radiotracer for in vivo PET imaging of the dopamine transport.
Ferrat M; Moein MM; Cananau C; Tegnebratt T; Saliba P; Norman F; Steiger C; Bratteby K; Samén E; Dahl K; Tran TA
Article: EJNMMI RADIOPHARMACY AND CHEMISTRY. 2023;8(1):41
Optimized, automated and cGMP-compliant synthesis of the HER2 targeting [⁶⁸Ga]Ga-ABY-025 tracer
Jussing E; Ferrat M; Moein MM; Alfredeen H; Tegnebratt T; Bratteby K; Samen E; Feldwisch J; Altena R; Axelsson R; Tran TA
Article: NATURE COMMUNICATIONS. 2023;14(1):6750
The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases
Smith R; Capotosti F; Schain M; Ohlsson T; Vokali E; Molette J; Touilloux T; Hliva V; Dimitrakopoulos IK; Puschmann A; Jogi J; Svenningsson P; Andreasson M; Sandiego C; Russell DS; Miranda-Azpiazu P; Halldin C; Stomrud E; Hall S; Bratteby K; Tampio L'Estrade E; Luthi-Carter R; Pfeifer A; Kosco-Vilbois M; Streffer J; Hansson O
Article: PHARMACEUTICALS. 2022;15(2):245
Development of 18F-Labeled Bispyridyl Tetrazines for In Vivo Pretargeted PET Imaging.
García-Vázquez R; Jørgensen JT; Bratteby KE; Shalgunov V; Hvass L; Herth MM; Kjær A; Battisti UM
Article: JOURNAL OF MEDICINAL CHEMISTRY. 2021;64(20):15297-15312
Development of the First Aliphatic ¹⁸F-Labeled Tetrazine Suitable for Pretargeted PET Imaging.Expanding the Bioorthogonal Tool Box
Battisti UM; Bratteby K; Jorgensen JT; Hvass L; Shalgunov V; Mikula H; Kjaer A; Herth MM
Article: ACS PHARMACOLOGY AND TRANSLATIONAL SCIENCE. 2021;4(5):1556-1566
Insights into Elution of Anion Exchange Cartridges: Opening the Path toward Aliphatic ¹⁸F-Radiolabeling of Base-Sensitive Tracers
Bratteby K; Shalgunov V; Battisti UM; Petersen IN; van den Broek SL; Ohlsson T; Gillings N; Erlandsson M; Herth MM
Article: PHARMACEUTICALS. 2021;14(7):601
Fully Automated GMP-Compliant Synthesis of [¹⁸F]FE-PE2I
Bratteby K; Denholt CL; Lehel S; Petersen IN; Madsen J; Erlandsson M; Ohlsson T; Herth MM; Gillings N
Article: ACS PHARMACOLOGY AND TRANSLATIONAL SCIENCE. 2021;4(2):824-833
Lipophilicity and Click Reactivity Determine the Performance of Bioorthogonal Tetrazine Tools in Pretargeted In Vivo Chemistry
Steen EJL; Jorgensen JT; Denk C; Battisti UM; Norregaard K; Edem PE; Bratteby K; Shalgunov V; Wilkovitsch M; Svatunek D; Poulie CBM; Hvass L; Simon M; Wanek T; Rossin R; Robillard M; Kristensen JL; Mikula H; Kjaer A; Herth MM
Article: JOURNAL OF MEDICINAL CHEMISTRY. 2020;63(2):747-755
In Vivo Veritas: ¹⁸F-Radiolabeled Glycomimetics Allow Insights into the Pharmacological Fate of Galectin-3 Inhibitors
Bratteby K; Torkelsson E; L'Estrade ET; Peterson K; Shalgunov V; Xiong M; Leffler H; Zetterberg FR; Olsson TG; Gillings N; Nilsson UJ; Herth MM; Erlandsson M
Article: JOURNAL OF IMMUNOLOGY. 2016;197(8):3415-3424
Quantitative Mass Spectrometry To Study Inflammatory Cartilage Degradation and Resulting Interactions with the Complement System
Furst CM; Ahrman E; Bratteby K; Waldemarson S; Malmstrom J; Blom AM

All other publications

Review: CHEMMEDCHEM. 2021;16(17):2612-2622
Aliphatic ¹⁸F-Radiofluorination: Recent Advances in the Labeling of Base-Sensitive Substrates**
Bratteby K; Shalgunov V; Herth MM

Articles

All other publications

News from KI

Events from KI